Photo: South Dakota Farmers Union
Texas Agriculture Commissioner Sid Miller praised the U.S. Food and Drug Administration for granting conditional approval of Exzolt Cattle-CA1, the first topical drug ever approved in the United States to treat and control both New World screwworm and Cattle Fever Tick in cattle. Miller called the decision a landmark achievement for livestock health and a major victory for the nation’s cattle industry.
“The threat posed to our cattle industry by these dangerous pests is substantial. The New World screwworm can destroy an animal in a matter of days, and the Cattle Fever Tick once brought the Texas cattle industry to its knees,” Commissioner Miller said. “This treatment gives our producers the modern, science-backed tools they need to keep herds safe and will help safeguard everything from small family herds to the nation’s major beef operations.”
The FDA’s decision comes at a crucial time. In recent months, New World screwworm has been detected in northern Mexico, including within 120 miles of the U.S. border. Meanwhile, the Cattle Fever Tick quarantine zone along the Rio Grande continues to experience heavy pressure due to wildlife movement, climate conditions, and cross-border livestock transport.
Exzolt Cattle-CA1 represents a significant scientific advancement. The treatment uses a topical formulation that absorbs through the skin and targets both external parasites and systemic infections, reducing stress on animals and improving usability for ranchers. The product is approved for cattle of different ages and production cycles, including calves, replacement heifers, bulls, and lactating cows.
Texas Department of Agriculture
Comments